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Acute coronary syndrome [ACS, including unstable angina (UA) or myocardial infarction 
(MI)] events can be psychologically traumatic experiences for patients given their 
unpredictable, sudden onset and life-threatening nature.1 Although posttraumatic stress 
disorder (PTSD) is commonly associated with index events of war or assault, PTSD is also 
associated with life-threatening illness and in particular ACS with approximately 12% of 
patients developing PTSD.1, 2
PTSD due to ACS has a multitude of consequences, including increased risk of ACS 
recurrence and mortality3, 4 in addition to PTSD itself being a debilitating psychiatric 
condition. Sufferers of PTSD are burdened by symptoms that include re-experiencing the 
traumatic event via intrusive thoughts, flashbacks, or nightmares; avoiding reminders of the 
index event; persistent negative alterations in cognition and mood; or physiologic 
hyperarousal. As such, ACS-induced PTSD is likely associated with substantial detriment in 
quality of life (QOL).However, few studies have measured this association, and no study has 
investigated it among a general ACS population or longitudinally. Rather, prior studies were 
comprised of ACS patients only in intensive care units(ICUs) or among armed-services 
veterans5,6, 7 or are notable for limitations such as cross-sectional designs.5, 8
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This study investigates the longitudinal QOL burden of PTSD due to ACS in order to 
determine 1) whether ACS-induced PTSD affects post-ACS QOL at multiple, discrete time 
points during the one year following the index event; and 2) whether PTSD is associated 
with change in QOL over time.
Patients were enrolled in the Prescription Use, Lifestyle, Stress Evaluation (PULSE) 
observational, prospective cohort study of ACS patients between February 2009 and 
October 2012 at Columbia University Medical Center. The subset of 345 PULSE patients 
with available PTSD symptom data was selected. All participants gave written informed 
consent. The Institutional Review Board of Columbia University Medical Center provided 
ethics approval for this study.
PTSD symptoms were assessed at 1 month by self-report using the Impact of Events Scale-
Revised (IES-R), with PTSD considered present if the scale total was at least 24.9 Quality of 
life was assessed in hospital and at 1, 6, and 12 months post-ACS by the Medical Outcomes 
Study 12-item Short-Form Health Survey (SF-12), from which a mental composite score 
(MCS) and a physical composite score(PCS) – from 0 to 100, with higher scores indicating 
better QOL – were derived.
QOL among patients with versus without PTSD was analyzed via multi-level repeated 
measures analyses of variance (ANOVAs), allowing for inclusion of subjects who have 
incomplete series of repeated QOL measures without relying on data imputation. QOL data 
was missing for 5 (1.4%) patients at baseline, 66 (19.1%) at 1 month, 81 (23.5%) at 6 
months, and 42 (12.2%) at 12 months. Covariates were selected a priori: baseline QOL, age, 
sex, race, ethnicity, prior history of MI, GRACE risk score, Charlson co-morbidity index, 
left ventricular ejection fraction (LVEF) greater than or equal to 40%, and baseline/in 
hospital depression (Beck Depression Inventory (BDI) with a cutoff of 10 or greater to 
categorize depression).
Baseline characteristics are presented in the Table. Twenty-five (7.2%) patients were 
categorized as having PTSD. Participants with PTSD were more likely to have a history of 
prior MI and were more likely to have depression at baseline.
Patients with ACS-induced PTSD reported significantly worse mental QOL both in-hospital 
and 1 month post-ACS in the fully adjusted multivariable models with mean score 
differences of 5.9 (95% CI 1.9–9.9, p = 0.0039) and 9.0 (95%%CI 4.9–13.1, p = <0.0001), 
respectively (see Figure).The unadjusted mental QOL difference associated with PTSD 
persisted at 6 and 12 months but was not statistically significant after adjusting for all 
covariates (mean score differences 7.8 (95%CI 3.2–12.4, p = 0.0009 and 5.1 (95%CI 0.6–
9.6, p = 0.03), respectively).
Mental QOL in the PTSD group increased substantially with a significant trend in overall 
change during the 12-month post-ACS follow-up in the fully adjusted model(3.3 (95%CI 
1.2–5.3),p = 0.002). The trend in change in mental QOL was not significant among ACS 
patients without PTSD. The trend in change was significantly different between the two 
groups(3.8 (95%CI 1.6–5.9), p = 0.0006).
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With regard to changes in mental QOL scores between specific time points, mental QOL 
improved more from 1 to 6 months and from 1 to 12 months among ACS patients with 
PTSD than among those without PTSD in the fully adjusted models (mean difference 
change = 5.1 (95%CI 0.7–9.6, p = 0.0005 and mean difference change = 7.6 (95%CI 3.4–
11.9, p = 0.0005, respectively).
Therefore, in this small sample of ACS patients, those who develop significant PTSD 
symptoms endure a significantly greater detriment in QOL compared to those without 
PTSD. During the subsequent year, however, post-ACS QOL improves among patients with 
PTSD significantly more than it does among those without PTSD, such that by 6 to 12 
months post-ACS the QOL among patients who developed PTSD is indistinguishable from 
that among patients who did not develop PTSD.
Our study is the first to show that the QOL detriment associated with post-ACS PTSD may 
be short-lived; other studies noted PTSD due to ACS was associated with poorer QOL for as 
many as 8 years.6 However, many trauma-related PTSD patients develop symptoms that are 
marked at 1 month post-event but resolve spontaneously over moderate time periods,10 
which could in turn influence resolution of poorer QOL. Because of our small sample size 
and single assessment of PTSD symptoms, identifying trajectories of PTSD and QOL in our 
sample was not possible. An additional explanation for our results could be that other studies 
on ACS-induced PTSD and QOL examined ICU patients exclusively, and stressful ICU-
related events may result in more persistent PTSD symptoms.
Regardless, even if the QOL impact of PTSD is relatively short-lived, the mean mental QOL 
score at 1 month post-ACS for participants with PTSD was more than 2.5 standard errors 
below that of patients who did not develop PTSD. It is possible that targeting factors that 
predispose patients to developing PTSD in the setting of ACS may improve both 
cardiovascular and QOL outcomes.
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Differences in mental quality of life in the one year post-ACS, according to SF-12 MCS, 
among patients with versus without PTSD due to ACS. [see separate file]
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Table
Patient characteristics at baseline by ACS-induced PTSD status
Characteristics No PTSD (n = 320) PTSD (n = 25) P value
Age (years) 63.4 60.9 0.301
Sex (female) 101 (31.5%) 11 (44%) 0.266
Race 0.501
-White 197 (61.6%) 12 (48.0%)
-Black 70 (21.9%) 10 (40.0%)
-Asian 5 (0.2%) 1 (0.04%)
Ethnicity (Hispanic) 126 (39.4%) 11 (44%) 0.675
Prior history of MI 0.024*
-No 225 (70.3%) 11 (44%)
-Yes 89 (27.8%) 13 (52%)
-Maybe 6 (0.2%) 1 (0.04%)
GRACE 91.0 85.6 0.376
Charlson 1.6 1.5 0.864
LVEF ≥ 40% 274 (85.6%) 19 (76%) 0.240
Baseline depression (BDI score ≥ 10) 99 (30.9%) 17 (68%) <0.001*
Abbreviations: QOL, quality of life; SF-12, Medical Outcomes Study 12-item Short-Form Health Survey; MCS, mental component summary; PCS, 
physical component summary; MI, myocardial infarction; BDI, Beck Depression Inventory
*
P-value < 0.05
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